CAS 2004677-13-6

Formule : C14H20FN5O

InChI : InChI=1S/C14H20FN5O/c1-3-4-5-14(2,8-21)20-12-11-10(18-13(16)19-12)6-9(15)7-17-11/h6-7,21H,3-5,8H2,1-2H3,(H3,16,18,19,20)/t14-/m0/s1

Code InChI : HTCJUBZBSJQWBW-AWEZNQCLSA-N

SMILES : CCCC[C@@](C)(CO)NC1=NC(=NC2=C1N=CC(=C2)F)N

(R)-2-((2-Amino-7-fluoropyrido[3,2-d]pyrimidin-4-yl)amino)-2-methylhexan-1-ol

CAS : 2004677-13-6

(R)-2-((2-Amino-7-fluoropyrido[3,2-d]pyrimidin-4-yl)amino)-2-methylhexan-1-ol

Formule : C₁₄H₂₀FN₅O

Degré de pureté : 98%

Masse moléculaire : 293.35

Ref: 54-PC1007935

(R)-2-((2-Amino-7-Fluoropyrido[3,2-D]Pyrimidin-4-Yl)Amino)-2-Methylhexan-1-Ol

CAS : 2004677-13-6

Degré de pureté : 98%

Ref: IN-DA01N18Z

Selgantolimod

CAS : 2004677-13-6

(R)-2-((2-Amino-7-fluoropyrido[3,2-d]pyrimidin-4-yl)amino)-2-methylhexan-1-ol

Formule : C₁₄H₂₀FN₅O

Degré de pureté : 98%

Masse moléculaire : 293.34

Ref: IN-DG01182759

Selgantolimod

CAS : 2004677-13-6

Selgantolimod is a small molecule that has been shown to be effective against hepatitis. This drug is structurally similar to the toll-like receptor ligands, which are involved in the immune response to infection. Selgantolimod is a potent inhibitor of the signal pathways that regulate cell death and survival. The molecular mechanism of this drug is not yet fully understood, but it has been shown to inhibit the synthesis of proteins by inhibiting polymerase chain reactions and triggering an antibody response. Selgantolimod may also be used as a diagnostic tool for chronic viral hepatitis or solid tumours.

Formule : C₁₄H₂₀FN₅O

Degré de pureté : Min. 95%

Masse moléculaire : 293.35 g/mol

Ref: 3D-BS178543

Selgantolimod

CAS : 2004677-13-6

Selgantolimod is an effective and selective toll-like receptor 8 agonists for the treatment of the hepatitis B virus and human immunodeficiency virus infection.

Formule : C₁₄H₂₀FN₅O

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 293.34

Ref: TM-T16870